Cambridge Cognition Holdings Plc CANTAB® incorporated in population health platform

Cambridge Cognition Holdings Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Cambridge Cognition Holdings plc (LON:COG), the digital neuroscience company which develops and markets digital solutions to assess brain health, has today announced a commercial collaboration with digital health provider Healthy Amplified, which sees the Company’s CANTAB® technology incorporated into a newly launched population health platform.

Healthy Amplified bridges the communication gap between healthcare providers, trainers, parents and youth sports caregivers. The inclusion of the gold standard cognitive assessment technology expands its offering to adults, facilitating the standardised testing of cognitive abilities, with a specific focus on assessing traumatic brain injury, depression, and the early detection of cognitive impairment associated with Alzheimer’s disease.

Under the collaboration, Healthy Amplified will act as a reseller of CANTAB products in US health markets, anticipating full rollout of its population health platform across 35 US Metropolitan Markets by the end of 2018.

Dr Steven Powell, CEO, Cambridge Cognition Holdings plc, said: “Through this collaboration we hope to widen the distribution channels of our medical software products to an established customer base in the US healthcare market.”

William H. Nelson, CEO, Healthy Amplified, said: “By incorporating leading neurocognitive CANTAB technology, we are advancing our mission to provide population health management solutions available for adult populations.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Cambridge Cognition Holdings plc announces the formation of a Scientific Advisory Board to guide brain health strategies and market trends effectively.
Cambridge Cognition Holdings plc partners with ActiGraph to enhance brain health assessments in clinical trials, aiming to improve treatments for CNS disorders.
Cambridge Cognition Holdings plc has announced the appointment of Stuart Gall and Philip Rodgers as independent non-executive Directors, to support the company's growth plans in the healthcare and technology sectors.

Search

Search